Literature DB >> 19545869

Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study.

Pedro Valdivielso1, Miguel Angel Sánchez-Chaparro, Eva Calvo-Bonacho, Martha Cabrera-Sierra, Juan Carlos Sainz-Gutiérrez, Carlos Fernández-Labandera, Ana Fernández-Meseguer, Luis Quevedo-Aguado, Montserrat Ruiz Moraga, Adolfo Gálvez-Moraleda, Arturo González-Quintela, Javier Roman-Garcia.   

Abstract

AIM: To study the prevalence, risk factors, and vascular disease associated with moderate and severe hypertriglyceridemia in an active working population. DESIGN AND METHODS: Cross-sectional study of 594,701 workers from all Spanish geographical areas, occupation sectors, ages, and sexes who underwent a yearly routine checkup. Data collected from participants included age, sex, anthropometric measurements, vascular risk factors, lipidic profile and basic biochemical analysis, from a fasting blood sample. A cardiovascular risk assessment was performed.
RESULTS: The study population included 428,334 males and 166,367 females, mean age 36+/-10 years. A total of 95,673 (16%) workers had mild hypertriglyceridemia (HTg) (Tg 150-399mg/dL), 7,081 (1.1%) had moderate HTg (400-999mg/dL), and 224 (0.03%) had severe HTg (>or=1000mg/dL). Of workers with hypertriglyceridemia, 90% were male. Age, obesity, type 1 and 2 diabetes, alcohol consumption, and vascular disease were associated with hypertriglyceridemia. Cardiovascular risk gradually increased for each HTg category. Amongst risk factors, the major independent predictor of mild-HTg was obesity (OR 2.42, CI 95% 2.37-2.48), whereas diabetes was a predictor of moderate HTg (OR 3.64, CI 95% 3.17-4.18) and severe HTg (OR 7.35, CI 95% 4.27-12.66). In multivariate analyses, HTg was gradually associated with vascular disease, even after adjusting for other risk factors.
CONCLUSION: In this working population, preventive programs for HTg and associated vascular disease should consider obesity-diabetes control as its first objective.

Entities:  

Mesh:

Year:  2009        PMID: 19545869     DOI: 10.1016/j.atherosclerosis.2009.05.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients--a randomized crossover trial.

Authors:  Yun Li; Qiong-hong Xie; Huai-zhou You; Jing Tian; Chuan-ming Hao; Shan-yan Lin; Tong-ying Zhu
Journal:  Perit Dial Int       Date:  2012-03-01       Impact factor: 1.756

2.  Vitamin D₃ prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats.

Authors:  Nicéia Spanholi Calgaroto; Pauline da Costa; Andréia Machado Cardoso; Luciane Belmonte Pereira; Juliano Marchi Vieira; Diéssica Dalenogare; Luana Paula Pelinson; Jucimara Baldissarelli; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

3.  The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis.

Authors:  M Hassan Murad; Ahmad Hazem; Fernando Coto-Yglesias; Svitlana Dzyubak; Shabnum Gupta; Irina Bancos; Melanie A Lane; Patricia J Erwin; Lars Berglund; Tarig Elraiyah; Victor M Montori
Journal:  BMC Endocr Disord       Date:  2012-03-31       Impact factor: 2.763

4.  Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.

Authors:  María-José Ariza; Miguel-Angel Sánchez-Chaparro; Francisco-Javier Barón; Ana-María Hornos; Eva Calvo-Bonacho; José Rioja; Pedro Valdivielso; José-Antonio Gelpi; Pedro González-Santos
Journal:  BMC Med Genet       Date:  2010-04-29       Impact factor: 2.103

5.  Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.

Authors:  Sandra Kutkienė; Žaneta Petrulionienė; Aleksandras Laucevičius; Marija Petrylaitė; Diana Maskeliūnaitė; Roma Puronaitė; Milda Kovaitė; Irma Kalibaitaitė; Egidija Rinkūnienė; Vilma Dženkevičiūtė; Vytautas Kasiulevičius
Journal:  Lipids Health Dis       Date:  2018-04-19       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.